Abbott announced late-breaking data for its next-generation Navitor transcatheter aortic valve implantation system. Results from the study supported Navitor's recent U.S. Food and Drug...
Abbott and Cardiovascular Systems, Inc, announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in...
Abbott announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in treating people with a range of structural heart...
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy....
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company's CardioMEMS™ HF System to support the...
